Table 3 Cox Regression of Risk of Death in Association with MCM2, Ki-67, and Gelsolin in 128 Patients with NSCLC, RPCI, 1995–1999
From: Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
Variables | Crude RR (95%CI) | P value | Adjusted RR (95%CI)* | P value |
|---|---|---|---|---|
MCM2†|  |  |  |  |
   Low (n = 49) | 1.00 |  | 1.00 |  |
   High (n = 79) | 1.51 (0.94–2.41) | 0.09 | 1.36 (0.84–2.20) | 0.22 |
Ki-67 ‡ |  |  |  |  |
   Low (n = 28) | 1.00 |  | 1.00 |  |
   High (n = 100) | 0.70 (0.27–1.86) | 0.47 | 0.59 (0.22–1.61) | 0.30 |
Gelsolin †|  |  |  |  |
   Low (n = 86) | 1.00 |  | 1.00 |  |
   High (n = 42) | 1.89 (1.20–2.98) | 0.006 | 1.89 (1.17–3.05) | 0.01 |
Gelsolin and MCM2 †|  |  |  |  |
   Both low (n = 37) | 1.00 |  | 1.00 |  |
   GSN low, MCM2 high (n = 49) | 1.34 (0.74–2.42) | 0.33 | 1.34 (0.73–2.45) | 0.34 |
   GSN high, MCM2 low (n = 12) | 1.62 (0.70–3.73) | 0.26 | 2.08 (0.87–4.98) | 0.10 |
   GSN high, MCM2 high (n = 30) | 2.59 (1.39–4.80) | 0.003 | 2.32 (1.21–4.45) | 0.01 |